FIGURE 3.
Prognostic analysis of TICS model in the training cohorts and validation cohorts. (A) Prognosis analysis of TICS in all PDAC cohorts (High vs. Low TICS). Kaplan–Meier survival curve of the overall survival (OS) in PDAC patients with high TICS and low TICS in TCGA-PAAD-US (n = 146) (B), ICGC-PACA-CA (n = 182) (C), ICGC-PACA-AU (n = 267) (D), GSE62452 (n = 66) (E), GSE71729 (n = 125) (F), and GSE57495 (n = 63) (G). Kaplan–Meier survival curve of recurrence-free survival in PDAC patients with high TICS and low TICS in TCGA-PAAD-US (n = 146) (H), and ICGC-PACA-AU (n = 267) (I). (J) Prognosis analysis of TICS in Pan-Cancers (High vs. Low TICS).